Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026)
Quanterix (QTRX) posted Non-Current Deffered Revenue of $2.8 million for Q1 2026, down 52.06% on a QoQ basis from $5.8 million in Q4 2025, and up 154.55% year-over-year from $1.1 million in Q1 2025.
Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Quanterix's Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 154.55% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 154.55% YoY) and the FY2025 annual result came in at $5.8 million, up 443.34% from the prior year.
- Non-Current Deffered Revenue was $2.8 million for Q1 2026 at Quanterix, down from $5.8 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $7.3 million in Q3 2025 and bottomed at $884000.0 in Q3 2024.
- A 5-year average of $1.9 million and a median of $1.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue sank 34.25% — and 2025, when it jumped 730.43%.
- Quanterix's Non-Current Deffered Revenue stood at $1.4 million in 2022, then fell by 13.29% to $1.2 million in 2023, then dropped by 12.55% to $1.1 million in 2024, then jumped by 443.34% to $5.8 million in 2025, then slumped by 52.06% to $2.8 million in 2026.
- Business Quant data shows QTRX's Non-Current Deffered Revenue at $2.8 million in Q1 2026, $5.8 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 884,000.00 |
| Jun 30, 2024 | 928,000.00 |
| Mar 31, 2024 | 933,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 929,000.00 |
| Jun 30, 2021 | 740,000.00 |